COMMUNIQUÉS West-GlobeNewswire

CARBIOS et Selenis annoncent un partenariat stratégique pour la production de PETG issu de la technologie de biorecyclage de CARBIOS pour les marchés de la cosmétique et de la santé

24/09/2024 - 18:00

Clermont-Ferrand (France), le mardi 24 septembre 2024 (18h00 CEST) : CARBIOS (Euronext Growth Paris: ALCRB), pionnière dans le développement et l'industrialisation de technologies biologiques pour réinventer le cycle de [...]

Eurobio Scientific : RESULTAT DU 1ER SEMESTRE 2024

24/09/2024 - 18:00

RESULTAT DU 1 ER SEMESTRE 2024 Progression du chiffre d’affaires à +12% à périmètre constant (+24% au total) Stabilité de l’EBITDA et du résultat opérationnel ajustés 1 Dette financière nette en légère baisse à 1,6 M€, [...]

Eurobio Scientific: RESULTS FOR THE 1ST HALF OF 2024

24/09/2024 - 18:00

RESULTS FOR THE 1 ST HALF OF 2024 Revenues up 12% on a like-for-like basis (24% overall) Stable adjusted EBITDA 1 and operating profit Net financial debt down slightly to €1.6m, with cash of €86.6m Proposed voluntary [...]

Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines

24/09/2024 - 17:30

Contract will further strengthen the U.S, bulk vaccine inventory and secure additional freeze-dried doses Deliveries planned for 2025 and beyond COPENHAGEN, Denmark, September 24, 2024 – Bavarian Nordic A/S (OMX: BAVA) [...]

Tevogen Bio Leadership Meets Members of U.S. Congress to Advocate for Long COVID Patients and Highlights Achievements and Assets as a Blueprint for Biotech Innovation

24/09/2024 - 17:09

WARREN, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified [...]

Appointment of Dr. Kalpesh Barot, MD Completes Phase One of ADIA Nutrition’s Medical Division

24/09/2024 - 16:00

WINTER PARK, Fla., Sept. 24, 2024 (GLOBE NEWSWIRE) -- ADIA Nutrition (OTC Pink: ADIA) is excited to announce the completion of its Board of Medical Directors with the appointment of Dr. Kalpesh Barot, MD, a [...]

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

24/09/2024 - 15:30

Minimally invasive technology would allow for percutaneous placement of a paddle electrode Renowned pain specialist Dr. Sean Li to present on this innovative tool for lower back pain EDEN PRAIRIE, Minn., Sept. 24, 2024 [...]

AAMI, CTA to Collaborate on AI Standards

24/09/2024 - 15:25

Arlington, Virginia, Sept. 24, 2024 (GLOBE NEWSWIRE) -- As artificial intelligence (AI) becomes more integrated into the healthcare sector, there is a pressing need for industry standards that will protect patients and [...]

GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024

24/09/2024 - 15:15

SAN FRANCISCO, CALIFORNIA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the [...]

Lighthouse Autism Center Announces Expansion of ABA Services in Iowa

24/09/2024 - 15:00

Leading ABA Provider Set to Open Newest Location in Cedar Rapids, IA. CEDAR RAPIDS, Iowa, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Lighthouse Autism Center, a premier provider of center-based Applied Behavior Analysis (ABA) [...]

Georgiamune Announces First Participant Dosed in First-In-Class Phase 1 Healthy Volunteers Trial of GIM-407

24/09/2024 - 15:00

Georgiamune continues biotech innovation streak with first autoimmune disease-focused program based on novel biology GAITHERSBURG, Md., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc . , a privately held, [...]

Conception Nurseries Launches TrueClones™ X

24/09/2024 - 15:00

The Industry’s First Generation Zero Hardened Tissue-Cultured Clones Provides Cannabis Cultivators With a Faster Path to Profit SACRAMENTO, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Conception Nurseries , the world’s [...]

Tersa Earth and Silica-X Sign MoU to Revolutionize Mining and Waste Management with AI-Powered Biotech and Zero-Waste Solutions

24/09/2024 - 15:00

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Fresh off its recognition as a Top Innovator in the World Economic Forum’s (WEF) Sustainable Mining Challenge, Tersa Earth Innovations Inc. announces signing a Memorandum of [...]

Curium Announces the Official Opening its New Netherlands Facility for the Production of Lutetium-177 – a Game Changer Therapy Isotope for Cancer Patients Worldwide

24/09/2024 - 14:45

The new Lu-177 production facility further solidifies Curium’s position as a global leader in nuclear medicine Curium will ensure a continuous supply of Lu-177 to benefit more than 100,000 cancer patients worldwide over [...]

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology – Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

24/09/2024 - 14:45

VANCOUVER, British Columbia, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) reports that it will be presenting the Company’s [...]

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

24/09/2024 - 14:30

Boehringer is advancing the development of SZN-413 to prepare it for potential future clinical testing SZN-413 is a bi-specific antibody targeting Frizzled Class Receptor 4 (Fzd4) mediated Wingless/Integrated (Wnt) [...]

CytoDyn Announces Preliminary Findings in Study with SMC Laboratories

24/09/2024 - 14:30

VANCOUVER, Washington, Sept. 24, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple [...]

Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials

24/09/2024 - 14:30

An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Oral Simufilam in On-going Phase 3 Trials. The DSMB Recommended Both Phase 3 Trials Continue as Planned, [...]

Enlivex Announces Positive DSMB Recommendation to Initiate the Phase II Stage of its Phase I/II Trial of Allocetra in Patients with Moderate to Severe Knee Osteoarthritis

24/09/2024 - 14:30

Nes-Ziona, Israel, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the independent Data [...]